ANTI-LEUKEMIC ACTIVITY AND CARDIAC TOXICITY OF 4-DEMETHOXYDAUNORUBICIN (4-DMD) IN MICE

被引：0

作者：

CASAZZA, AM

BERTAZZOLI, C

PRATESI, G

BELLINI, O

MARCO, AD

机构：

[1] NATL TUMOR INST,MILANO,ITALY

[2] FARMITALIA RES LAB,MILANO,ITALY

来源：

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：16 / 16

页数：1

共 50 条

[31] Multicomponent assembly of 4-aza-podophyllotoxins: A fast entry to highly selective and potent anti-leukemic agents [J].

Jeedimalla, Nagalakshmi ;

Flint, Madison ;

Smith, Lyndsay ;

Haces, Alberto ;

Minond, Dmitriy ;

Roche, Stephane P. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 106 :167-179

[32] Lentiviral transduction of INK4A/ARF protein cooperates with anti-leukemic agents to induce apoptosis of leukemia cells [J].

Bai, YS ;

Soda, Y ;

Chen, MH ;

Izawa, K ;

Kobayashi, S ;

Tomonari, A ;

Ooi, J ;

Nagamura, F ;

Takahashi, S ;

Uchimaru, K ;

Iseki, T ;

Miyoshi, H ;

Takahashi, TA ;

Tani, K ;

Tojo, A ;

Asano, S .

MOLECULAR THERAPY, 2004, 9 :S254-S254

[33] Cytokine induced killer (CIK) cells transduced with an anti-CD19 chimeric receptor containing 4-1BB acquire powerful anti-leukemic activity. [J].

Marin, Vima ;

D'Amico, Giovanna ;

Kakuda, Harumi ;

Dander, Erica ;

Campana, Dario ;

Biondi, Andrea .

BLOOD, 2006, 108 (11) :931A-932A

[34] ACTIVITY OF (7) ANTHRACYCLINE RELATED-COMPOUNDS IN AN DOXORUBICIN SENSITIVE HUMAN SMALL-CELL LUNG-CANCER LINE AND ITS DOXORUBICIN RESISTANT DESCENDANT - ACTIVITY OF DOXORUBICIN, DAUNORUBICIN, 4-DEOXYRUBICIN, 4-DEMETHOXYDAUNORUBICIN, DETORUBICIN, 4'-EPIDOXORUBICIN AND MITOXANTRONE [J].

ZIJLSTRA, JG ;

MEIJER, C ;

TIMMERBOSSCHA, H ;

LE, TKP ;

DEVRIES, EGE ;

MULDER, NH .

EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1987, 70 :53-55

[35] Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia [J].

Zhou, Qi ;

Guan, Yongyu ;

Zhao, Pingping ;

Chu, Huiyuan ;

Xi, Yaming .

TRANSLATIONAL ONCOLOGY, 2025, 52

[36] Synthesis, biological evaluation and molecular docking studies of tetrahydropyrido[3, 4- d ]pyrimidine derivatives as anti-leukemic agents [J].

Parashuram, V. ;

Kumari, K. Aruna ;

Mullaguri, Sai Charitha ;

Kancha, Rama Krishna ;

Mittapelli, Vasantha .

RESULTS IN CHEMISTRY, 2024, 8

[37] Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential [J].

Tilekar, Kalpana ;

Upadhyay, Neha ;

Hess, Jessica D. ;

Macias, Lucasantiago Henze ;

Mrowka, Piotr ;

Aguilera, Renato J. ;

Meyer-Almes, Franz-Josef ;

Iancu, Cristina, V ;

Choe, Jun-yong ;

Ramaa, C. S. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 202

[38] ANTI-LEUKEMIC EFFICACY OF BET INHIBITOR TREATMENT IN A PRECLINICAL MODEL OF INFANT MLL-AF4+ACUTE LYMPHOBLASTIC LEUKEMIA [J].

Bardini, M. ;

Trentin, L. ;

Rizzo, F. ;

Vieri, M. ;

Savino, A. M. ;

Fazio, G. ;

Te Kronnie, G. ;

Basso, G. ;

Biondi, A. ;

Cazzaniga, G. .

HAEMATOLOGICA, 2016, 101 :S16-S16

[39] SYNTHESIS OF NOVEL 4′-TRIFLUOROMETHYL-5′-NORCARBOCYCLIC C-NUCLEOSIDE PHOSPHONIC ACIDS AS POTENT ANTI-LEUKEMIC AGENTS [J].

Kim, Seyeon ;

Hong, Joon Hee .

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2015, 34 (12) :848-865

[40] CARDIAC TOXICITY AND ANTITUMOR-ACTIVITY OF 4'-DEOXY-4'-IODO-DOXORUBICINOL [J].

DANESI, R ;

MARCHETTI, A ;

BERNARDINI, N ;

LAROCCA, RV ;

BEVILACQUA, G ;

DELTACCA, M .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (06) :403-408

← 1 2 3 4 5 →